Craft

Instem

Revenue

£58.9 M

FY, 2022

Instem Summary

Company Summary

Overview
Instem is a provider of IT applications targeted at the healthcare market. It offers data collection, management, and analysis, clinical trial transparency, preclinical, and discovery solutions. The company serves the pharmaceutical, government research, chemical, medical device, agrochemical, and academic research industries.
Type
Subsidiary
Status
Active
Founded
1969
HQ
Stone, GB | view all locations
Website
https://www.instem.com
Cybersecurity rating
ESG rating
40-49 out of 100|View all ESG data
Sectors

Key People

  • Gordon Baxter

    Gordon Baxter, Chief Scientific Officer

  • Phil Reason

    Phil Reason, Chief Executive Officer

  • Nigel Goldsmith

    Nigel Goldsmith, Chief Financial Officer

  • Adrian Gare

    Adrian Gare, Vice President, Corporate Development and Finance

Operating MetricsView all

Customers

700

H1, 2023

ARR

£41.1M
27.9%

H1, 2023

LocationsView all

12 locations detected

  • Stone, England HQ

    United Kingdom

    stone business park, 6 Emerald Way

  • Columbus, OH

    United States

  • Morrisville, NC

    United States

  • Shanghai, Shang Hai Shi

    China

    Room 218, Building 3, 690 Bibo Road, Zhangjiang High-Tech Park, Pudong District

  • Paris, IDF

    France

  • Pune, Maharashtra

    India

and 6 others

Instem Financials

Summary Financials

Revenue (H1, 2023)
£30.0M
Gross profit (H1, 2023)
£30.0M
Net income (H1, 2023)
(£93.0K)
Cash (H1, 2023)
£8.4M
EBIT (H1, 2023)
£955.0K

Footer menu